Oncolytics Biotech
ONCY
$1.17
Share price
-0.91%
Change (1 day)
-31.62%
Change (1 year)
Categories
Earnings for Oncolytics Biotech (ONCY)
Earnings in 2023 (TTM): -$25.21 M
According to Oncolytics Biotech 's latest financial reports the company's current earnings (TTM) are -$25.21 M. a decrease over its 2022 earnings that were of -$20.47 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Oncolytics Biotech from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023  | -$25.21 M | 23.15% |
| 2022 | -$20.47 M | -1.48% |
| 2021 | -$20.78 M | 9.3% |
| 2020 | -$19.01 M | 22.12% |
| 2019 | -$15.57 M | 22.79% |
| 2018 | -$12.68 M | 4.29% |
| 2017 | -$12.16 M | 4.6% |
| 2016 | -$11.63 M | 8.82% |
| 2015 | -$10.68 M | -37.12% |
| 2014 | -$16.99 M | -26.14% |
| 2013 | -$23 M | -37.42% |
| 2012 | -$36.74 M | 29.24% |
| 2011 | -$28.43 M | 45.97% |
| 2010 | -$19.48 M | 35.46% |
| 2009 | -$14.38 M | -14.08% |
| 2008 | -$16.74 M | -0.9% |
| 2007 | -$16.89 M | 24.65% |
| 2006 | -$13.55 M | 44.58% |
| 2005 | -$9.37 M | -11.18% |
| 2004 | -$10.55 M | 113.77% |
| 2003 | -$4.94 M | 0.05% |
| 2002 | -$4.94 M | -5.41% |
| 2001 | -$5.22 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | $7.56 B | -30,095.64% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | -$5.85 B | 23,091.97% | 🇺🇸 USA |
 Mirati Therapeutics MRTX | -$0.77 B | 2,934.36% | 🇺🇸 USA |
 Aeterna Zentaris AEZS | -$18.01 M | -28.56% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $0.40 B | -1,706.70% | 🇮🇱 Israel |
 AVEO Oncology
AVEO | -$29.04 M | 15.20% | 🇺🇸 USA |